Equity research systems like Zacks Investment Research frequently adjust quantitative rankings for micro-cap and clinical-stage biopharmaceutical companies like Perspective Therapeutics (CATX) based on shifting earnings estimate revisions and quarterly financial disclosures. Traders should consult live platforms like Zacks Investment Research to verify the exact real-time rating tier.